{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T15:29:23Z","timestamp":1794324563228,"version":"4.9.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T00:00:00Z","timestamp":1753315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"American Parkinson Disease Association Center for Advanced Research at the University of Pittsburgh"},{"DOI":"10.13039\/100023044","name":"Commonwealth of Pennsylvania","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100023044","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Friends and family of Sean Logan"},{"name":"Blechman Foundation"},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation","doi-asserted-by":"crossref","award":["MJFF-010316"],"award-info":[{"award-number":["MJFF-010316"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100017510","name":"UK Dementia Research Institute","doi-asserted-by":"publisher","award":["UKDRI-6205"],"award-info":[{"award-number":["UKDRI-6205"]}],"id":[{"id":"10.13039\/501100017510","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Edmond and Lily Safra Early Career Fellowship Program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Pesticide exposure is increasingly recognized as a potential environmental factor in idiopathic Parkinson\u2019s disease, though the molecular mechanisms remain unclear. This study explores how pesticide exposure alters gene regulation in key brain regions using the rotenone rat model. We performed H3K27ac ChIP-sequencing to profile active regulatory elements in the substantia nigra and motor cortex. Despite uniform complex I inhibition across regions, we observed region-specific epigenomic changes associated with rotenone exposure. RNA-sequencing confirmed transcriptomic alterations. We identified a strong, rotenone-induced immune response in the substantia nigra, including increased activity in the C1q complement pathway, suggesting immune involvement driven by regulatory mechanisms. In contrast, the cortex showed dysregulation of synaptic function at the gene regulatory level. Our results highlight a role for gene regulatory mechanisms potentially mediating the effects of pesticide exposure, driving region-specific functional responses in the brain that may contribute to the pathology and selective vulnerability that characterise Parkinson\u2019s disease.<\/jats:p>","DOI":"10.1038\/s41531-025-01049-1","type":"journal-article","created":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T09:03:37Z","timestamp":1753347817000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Unique nigral and cortical pathways implicated by epigenomic and transcriptional analyses in rotenone Parkinson\u2019s model"],"prefix":"10.1038","volume":"11","author":[{"given":"Maria","family":"Tsalenchuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Scheirer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqian","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Timothy Greenamyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Marzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,24]]},"reference":[{"key":"1049_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.3233\/JPD-181474","volume":"8","author":"ER Dorsey","year":"2018","unstructured":"Dorsey, E. R., Sherer, T., Okun, M. S. & Bloem, B. R. The emerging evidence of the Parkinson pandemic. J. Parkinsons Dis. 8, S3\u2013S8 (2018).","journal-title":"J. Parkinsons Dis."},{"key":"1049_CR2","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia, L. V. & Lang, A. E. Parkinson\u2019s disease. Lancet 386, 896\u2013912 (2015).","journal-title":"Lancet"},{"key":"1049_CR3","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.neuro.2012.05.011","volume":"33","author":"C Freire","year":"2012","unstructured":"Freire, C. & Koifman, S. Pesticide exposure and Parkinson\u2019s disease: epidemiological evidence of association. Neurotoxicology 33, 947\u2013971 (2012).","journal-title":"Neurotoxicology"},{"key":"1049_CR4","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/81834","volume":"3","author":"R Betarbet","year":"2000","unstructured":"Betarbet, R. et al. Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease. Nat. Neurosci. 3, 1301\u20131306 (2000).","journal-title":"Nat. Neurosci."},{"key":"1049_CR5","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.nbd.2009.01.016","volume":"34","author":"JR Cannon","year":"2009","unstructured":"Cannon, J. R. et al. A highly reproducible rotenone model of Parkinson\u2019s disease. Neurobiol. Dis. 34, 279 (2009).","journal-title":"Neurobiol. Dis."},{"key":"1049_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2019.104626","volume":"134","author":"EM Rocha","year":"2020","unstructured":"Rocha, E. M. et al. LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinson\u2019s disease. Neurobiol. Dis. 134, 104626 (2020).","journal-title":"Neurobiol. Dis."},{"key":"1049_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.toxlet.2019.09.024","volume":"318","author":"C Zhan","year":"2020","unstructured":"Zhan, C. et al. Rotenone and 3-bromopyruvate toxicity impacts electrical and structural cardiac remodeling in rats. Toxicol. Lett. 318, 57\u201364 (2020).","journal-title":"Toxicol. Lett."},{"key":"1049_CR8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.neuro.2018.02.013","volume":"65","author":"ME Johnson","year":"2018","unstructured":"Johnson, M. E., Stringer, A. & Bobrovskaya, L. Rotenone induces gastrointestinal pathology and microbiota alterations in a rat model of Parkinson\u2019s disease. Neurotoxicology 65, 174\u2013185 (2018).","journal-title":"Neurotoxicology"},{"key":"1049_CR9","doi-asserted-by":"publisher","first-page":"493","DOI":"10.3390\/jcm10030493","volume":"10","author":"C Skj\u00e6rb\u00e6k","year":"2021","unstructured":"Skj\u00e6rb\u00e6k, C., Knudsen, K., Horsager, J. & Borghammer, P. Gastrointestinal dysfunction in Parkinson\u2019s disease. J. Clin. Med. 10, 493 (2021).","journal-title":"J. Clin. Med."},{"key":"1049_CR10","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16110","volume":"31","author":"V Kincl","year":"2024","unstructured":"Kincl, V. et al. Parkinson\u00b4s disease cardiovascular symptoms: a new complex functional and structural insight. Eur. J. Neurol. 31, e16110 (2024).","journal-title":"Eur. J. Neurol."},{"key":"1049_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jns.2006.05.011","volume":"248","author":"H Braak","year":"2006","unstructured":"Braak, H., R\u00fcb, U. & Del Tredici, K. Cognitive decline correlates with neuropathological stage in Parkinson\u2019s disease. J. Neurol. Sci. 248, 255\u2013258 (2006).","journal-title":"J. Neurol. Sci."},{"key":"1049_CR12","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1002\/acn3.50857","volume":"6","author":"L Yu","year":"2019","unstructured":"Yu, L. et al. Common age-related neuropathologies and yearly variability in cognition. Ann. Clin. Transl. Neurol. 6, 2140\u20132149 (2019).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"1049_CR13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","volume":"16","author":"DJ Irwin","year":"2017","unstructured":"Irwin, D. J. et al. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis. Lancet Neurol. 16, 55\u201365 (2017).","journal-title":"Lancet Neurol."},{"key":"1049_CR14","doi-asserted-by":"publisher","first-page":"I15","DOI":"10.1007\/s00415-003-1103-1","volume":"250","author":"AO Ceballos-Baumann","year":"2003","unstructured":"Ceballos-Baumann, A. O. Functional imaging in Parkinson\u2019s disease: activation studies with PET, fMRI and SPECT. J. Neurol. 250, I15\u2013I23 (2003).","journal-title":"J. Neurol."},{"key":"1049_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.clinph.2004.11.017","volume":"116","author":"J-P Lefaucheur","year":"2005","unstructured":"Lefaucheur, J.-P. Motor cortex dysfunction revealed by cortical excitability studies in Parkinson\u2019s disease: influence of antiparkinsonian treatment and cortical stimulation. Clin. Neurophysiol. 116, 244\u2013253 (2005).","journal-title":"Clin. Neurophysiol."},{"key":"1049_CR16","doi-asserted-by":"publisher","unstructured":"Lindenbach, D. & Bishop, C. Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson\u2019s disease. Neurosci. Biobehav. Rev. 37, https:\/\/doi.org\/10.1016\/j.neubiorev.2013.09.008 (2013).","DOI":"10.1016\/j.neubiorev.2013.09.008"},{"key":"1049_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41531-023-00561-6","volume":"9","author":"AD Van Laar","year":"2023","unstructured":"Van Laar, A. D. et al. Transient exposure to rotenone causes degeneration and progressive parkinsonian motor deficits, neuroinflammation, and synucleinopathy. NPJ Parkinsons Dis. 9, 1\u20139 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"1049_CR18","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/s41593-018-0253-7","volume":"21","author":"SJ Marzi","year":"2018","unstructured":"Marzi, S. J. et al. A histone acetylome-wide association study of Alzheimer\u2019s disease identifies disease-associated H3K27ac differences in the entorhinal cortex. Nat. Neurosci. 21, 1618\u20131627 (2018).","journal-title":"Nat. Neurosci."},{"key":"1049_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13024-021-00450-7","volume":"16","author":"L Toker","year":"2021","unstructured":"Toker, L. et al. Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson\u2019s disease brain. Mol. Neurodegener. 16, 31 (2021).","journal-title":"Mol. Neurodegener."},{"key":"1049_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-023-00568-z","volume":"9","author":"M Tsalenchuk","year":"2023","unstructured":"Tsalenchuk, M., Gentleman, S. M. & Marzi, S. J. Linking environmental risk factors with epigenetic mechanisms in Parkinson\u2019s disease. NPJ Parkinsons Dis. 9, 1\u201312 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"1049_CR21","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/s41588-021-00921-z","volume":"53","author":"DP Wightman","year":"2021","unstructured":"Wightman, D. P. et al. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer\u2019s disease. Nat. Genet 53, 1276\u20131282 (2021).","journal-title":"Nat. Genet"},{"key":"1049_CR22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/bpa.12511","volume":"28","author":"G Santpere","year":"2017","unstructured":"Santpere, G. et al. Transcriptional network analysis in frontal cortex in Lewy body diseases with focus on dementia with Lewy bodies. Brain Pathol. 28, 315\u2013333 (2017).","journal-title":"Brain Pathol."},{"key":"1049_CR23","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1096\/fj.02-0963fje","volume":"17","author":"M Heidbreder","year":"2003","unstructured":"Heidbreder, M. et al. Hypoxia rapidly activates HIF-3alpha mRNA expression. FASEB J. 17, 1541\u20131543 (2003).","journal-title":"FASEB J."},{"key":"1049_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-023-02490-7","volume":"13","author":"K Xu","year":"2023","unstructured":"Xu, K. et al. LRFN5 and OLFM4 as novel potential biomarkers for major depressive disorder: a pilot study. Transl. Psychiatry 13, 188 (2023).","journal-title":"Transl. Psychiatry"},{"key":"1049_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/lifemeta\/load001","volume":"2","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Inter-tissue communication of mitochondrial stress and metabolic health. Life Metab. 2, load001 (2023).","journal-title":"Life Metab."},{"key":"1049_CR26","doi-asserted-by":"publisher","first-page":"14217","DOI":"10.1096\/fj.202001046R","volume":"34","author":"P Deshpande","year":"2020","unstructured":"Deshpande, P. et al. Protein synthesis is suppressed in sporadic and familial Parkinson\u2019s disease by LRRK2. FASEB J. 34, 14217\u201314233 (2020).","journal-title":"FASEB J."},{"key":"1049_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105685","volume":"167","author":"SM Rocha","year":"2022","unstructured":"Rocha, S. M. et al. Rotenone induces regionally distinct \u03b1-synuclein protein aggregation and activation of glia prior to loss of dopaminergic neurons in C57Bl\/6 mice. Neurobiol. Dis. 167, 105685 (2022).","journal-title":"Neurobiol. Dis."},{"key":"1049_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15626-w","volume":"11","author":"CS Lindestam Arlehamn","year":"2020","unstructured":"Lindestam Arlehamn, C. S. et al. \u03b1-Synuclein-specific T cell reactivity is associated with preclinical and early Parkinson\u2019s disease. Nat. Commun. 11, 1875 (2020).","journal-title":"Nat. Commun."},{"key":"1049_CR29","doi-asserted-by":"publisher","first-page":"163","DOI":"10.14348\/molcells.2017.0011","volume":"40","author":"Y Fan","year":"2017","unstructured":"Fan, Y., Xie, L. & Chung, C. Y. Signaling pathways controlling microglia chemotaxis. Mol. Cells 40, 163\u2013168 (2017).","journal-title":"Mol. Cells"},{"key":"1049_CR30","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1084\/jem.20052144","volume":"203","author":"JM Burns","year":"2006","unstructured":"Burns, J. M. et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J. Exp. Med. 203, 2201\u20132213 (2006).","journal-title":"J. Exp. Med."},{"key":"1049_CR31","doi-asserted-by":"publisher","first-page":"e1010116","DOI":"10.1371\/journal.pcbi.1010116","volume":"18","author":"C Liu","year":"2022","unstructured":"Liu, C. et al. Systems-level identification of key transcription factors in immune cell specification. PLoS Comput. Biol. 18, e1010116 (2022).","journal-title":"PLoS Comput. Biol."},{"key":"1049_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2024.102424","volume":"138","author":"L Ma","year":"2024","unstructured":"Ma, L. et al. Knockdown of IRF8 alleviates neuroinflammation through regulating microglial activation in Parkinson\u2019s disease. J. Chem. Neuroanat. 138, 102424 (2024).","journal-title":"J. Chem. Neuroanat."},{"key":"1049_CR33","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.15252\/embj.201591881","volume":"34","author":"G Bajic","year":"2015","unstructured":"Bajic, G., Degn, S. E., Thiel, S. & Andersen, G. R. Complement activation, regulation, and molecular basis for complement-related diseases. EMBO J. 34, 2735\u20132757 (2015).","journal-title":"EMBO J."},{"key":"1049_CR34","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/genes12030443","volume":"12","author":"SM Carpanini","year":"2021","unstructured":"Carpanini, S. M. et al. The impact of complement genes on the risk of late-onset Alzheimer\u2019s disease. Genes (Basel) 12, 443 (2021).","journal-title":"Genes (Basel)"},{"key":"1049_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-07179-3","volume":"12","author":"M Stillman","year":"2022","unstructured":"Stillman, M., Lautz, J. D., Johnson, R. S., MacCoss, M. J. & Smith, S. E. P. Activity dependent dissociation of the Homer1 interactome. Sci. Rep. 12, 3207 (2022).","journal-title":"Sci. Rep."},{"key":"1049_CR36","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1038\/s41380-020-00991-1","volume":"26","author":"S Yoon","year":"2021","unstructured":"Yoon, S. et al. Homer1 promotes dendritic spine growth through ankyrin-G and its loss reshapes the synaptic proteome. Mol. Psychiatry 26, 1775\u20131789 (2021).","journal-title":"Mol. Psychiatry"},{"key":"1049_CR37","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jphs.2020.07.011","volume":"144","author":"L Iovino","year":"2020","unstructured":"Iovino, L., Tremblay, M. E. & Civiero, L. Glutamate-induced excitotoxicity in Parkinson\u2019s disease: the role of glial cells. J. Pharm. Sci. 144, 151\u2013164 (2020).","journal-title":"J. Pharm. Sci."},{"key":"1049_CR38","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1159\/000230689","volume":"59","author":"V De Luca","year":"2009","unstructured":"De Luca, V. et al. HOMER1 promoter analysis in Parkinson\u2019s disease: association study with psychotic symptoms. Neuropsychobiology 59, 239\u2013245 (2009).","journal-title":"Neuropsychobiology"},{"key":"1049_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-015-0316-2","volume":"15","author":"S Zainal Abidin","year":"2015","unstructured":"Zainal Abidin, S. et al. DRD and GRIN2B polymorphisms and their association with the development of impulse control behaviour among Malaysian Parkinson\u2019s disease patients. BMC Neurol. 15, 59 (2015).","journal-title":"BMC Neurol."},{"key":"1049_CR40","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000072","volume":"2","author":"L Wang","year":"2016","unstructured":"Wang, L. et al. DNA variants in CACNA1C modify Parkinson disease risk only when vitamin D level is deficient. Neurol. Genet 2, e72 (2016).","journal-title":"Neurol. Genet"},{"key":"1049_CR41","doi-asserted-by":"publisher","first-page":"e99294","DOI":"10.1371\/journal.pone.0099294","volume":"9","author":"N Yamada-Fowler","year":"2014","unstructured":"Yamada-Fowler, N., Fredrikson, M. & S\u00f6derkvist, P. Caffeine interaction with glutamate receptor gene GRIN2A: Parkinson\u2019s disease in Swedish population. PLoS One 9, e99294 (2014).","journal-title":"PLoS One"},{"key":"1049_CR42","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41531-022-00278-y","volume":"8","author":"N Antoniou","year":"2022","unstructured":"Antoniou, N. et al. High content screening and proteomic analysis identify a kinase inhibitor that rescues pathological phenotypes in a patient-derived model of Parkinson\u2019s disease. NPJ Parkinsons Dis. 8, 15 (2022).","journal-title":"NPJ Parkinsons Dis."},{"key":"1049_CR43","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41531-023-00461-9","volume":"9","author":"S Kaiser","year":"2023","unstructured":"Kaiser, S. et al. A proteogenomic view of Parkinson\u2019s disease causality and heterogeneity. NPJ Parkinsons Dis. 9, 24 (2023).","journal-title":"NPJ Parkinsons Dis."},{"key":"1049_CR44","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.molbrainres.2004.11.007","volume":"134","author":"CM Testa","year":"2005","unstructured":"Testa, C. M., Sherer, T. B. & Greenamyre, J. T. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures. Brain Res. Mol. Brain Res. 134, 109\u2013118 (2005).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"1049_CR45","first-page":"2003","volume":"8","author":"C Guo","year":"2013","unstructured":"Guo, C., Sun, L., Chen, X. & Zhang, D. Oxidative stress, mitochondrial damage and neurodegenerative diseases. Neural Regen. Res. 8, 2003\u20132014 (2013).","journal-title":"Neural Regen. Res."},{"key":"1049_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108263","volume":"33","author":"HJR Fernandes","year":"2020","unstructured":"Fernandes, H. J. R. et al. Single-cell transcriptomics of Parkinson\u2019s disease human in vitro models reveals dopamine neuron-specific stress responses. Cell Rep. 33, 108263 (2020).","journal-title":"Cell Rep."},{"key":"1049_CR47","doi-asserted-by":"publisher","first-page":"3174","DOI":"10.3390\/biomedicines10123174","volume":"10","author":"S Thomas-Broome","year":"2022","unstructured":"Thomas-Broome, S. & Castorina, A. Systemic rotenone administration causes extra-nigral alterations in C57BL\/6 mice. Biomedicines 10, 3174 (2022).","journal-title":"Biomedicines"},{"key":"1049_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep45465","volume":"7","author":"S Heinz","year":"2017","unstructured":"Heinz, S. et al. Mechanistic investigations of the mitochondrial complex I inhibitor rotenone in the context of pharmacological and safety evaluation. Sci. Rep. 7, 45465 (2017).","journal-title":"Sci. Rep."},{"key":"1049_CR49","doi-asserted-by":"publisher","first-page":"5102","DOI":"10.1111\/febs.17076","volume":"291","author":"TD Williams","year":"2024","unstructured":"Williams, T. D. & Rousseau, A. Translation regulation in response to stress. FEBS J. 291, 5102\u20135122 (2024).","journal-title":"FEBS J."},{"key":"1049_CR50","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.3233\/JPD-223237","volume":"12","author":"N Stefanova","year":"2022","unstructured":"Stefanova, N. Microglia in Parkinson\u2019s disease. J. Parkinsons Dis. 12, S105\u2013S112 (2022).","journal-title":"J. Parkinsons Dis."},{"key":"1049_CR51","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/bs.pbr.2019.10.006","volume":"252","author":"AM Schonhoff","year":"2020","unstructured":"Schonhoff, A. M., Williams, G. P., Wallen, Z. D., Standaert, D. G. & Harms, A. S. Innate and adaptive immune responses in Parkinson\u2019s disease. Prog. Brain Res. 252, 169\u2013216 (2020).","journal-title":"Prog. Brain Res."},{"key":"1049_CR52","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s12640-009-9076-3","volume":"16","author":"M Shimoji","year":"2009","unstructured":"Shimoji, M., Pagan, F., Healton, E. B. & Mocchetti, I. CXCR4 and CXCL12 expression is increased in the nigro-striatal system of Parkinson\u2019s disease. Neurotox. Res. 16, 318\u2013328 (2009).","journal-title":"Neurotox. Res."},{"key":"1049_CR53","doi-asserted-by":"publisher","first-page":"3428","DOI":"10.1021\/acs.jproteome.0c01002","volume":"20","author":"S-X Ma","year":"2021","unstructured":"Ma, S.-X. et al. Complement and coagulation cascades are potentially involved in dopaminergic neurodegeneration in \u03b1-synuclein-based mouse models of Parkinson\u2019s disease. J. Proteome Res. 20, 3428\u20133443 (2021).","journal-title":"J. Proteome Res."},{"key":"1049_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-021-02225-9","volume":"18","author":"E Gregersen","year":"2021","unstructured":"Gregersen, E. et al. Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity. J. Neuroinflammation 18, 177 (2021).","journal-title":"J. Neuroinflammation"},{"key":"1049_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-3-29","volume":"3","author":"DA Loeffler","year":"2006","unstructured":"Loeffler, D. A., Camp, D. M. & Conant, S. B. Complement activation in the Parkinson\u2019s disease substantia nigra: an immunocytochemical study. J. Neuroinflammation 3, 29 (2006).","journal-title":"J. Neuroinflammation"},{"key":"1049_CR56","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/NEN.0b013e31820805b9","volume":"70","author":"C Depboylu","year":"2011","unstructured":"Depboylu, C. et al. Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease. J. Neuropathol. Exp. Neurol. 70, 125\u2013132 (2011).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"1049_CR57","doi-asserted-by":"publisher","first-page":"762","DOI":"10.4103\/1673-5374.249847","volume":"14","author":"M Bisbal","year":"2019","unstructured":"Bisbal, M. & Sanchez, M. Neurotoxicity of the pesticide rotenone on neuronal polarization: a mechanistic approach. Neural Regen. Res. 14, 762\u2013766 (2019).","journal-title":"Neural Regen. Res."},{"key":"1049_CR58","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.neuint.2012.11.011","volume":"62","author":"YW Yap","year":"2013","unstructured":"Yap, Y. W. et al. Gene expression profiling of rotenone-mediated cortical neuronal death: evidence for inhibition of ubiquitin-proteasome system and autophagy-lysosomal pathway, and dysfunction of mitochondrial and calcium signaling. Neurochem Int. 62, 653\u2013663 (2013).","journal-title":"Neurochem Int."},{"key":"1049_CR59","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.1007\/s00415-020-09863-8","volume":"268","author":"E Sarasso","year":"2021","unstructured":"Sarasso, E., Agosta, F., Piramide, N. & Filippi, M. Progression of grey and white matter brain damage in Parkinson\u2019s disease: a critical review of structural MRI literature. J. Neurol. 268, 3144\u20133179 (2021).","journal-title":"J. Neurol."},{"key":"1049_CR60","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40478-023-01711-w","volume":"12","author":"I Frigerio","year":"2024","unstructured":"Frigerio, I. et al. Regional differences in synaptic degeneration are linked to alpha-synuclein burden and axonal damage in Parkinson\u2019s disease and dementia with Lewy bodies. Acta Neuropathol. Commun. 12, 4 (2024).","journal-title":"Acta Neuropathol. Commun."},{"key":"1049_CR61","doi-asserted-by":"publisher","first-page":"5970","DOI":"10.1002\/alz.13479","volume":"19","author":"SJ Marzi","year":"2023","unstructured":"Marzi, S. J. et al. Artificial intelligence for neurodegenerative experimental models. Alzheimers Dement. 19, 5970\u20135987 (2023).","journal-title":"Alzheimers Dement."},{"key":"1049_CR62","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1126\/science.aay0793","volume":"366","author":"A Nott","year":"2019","unstructured":"Nott, A. et al. Brain cell type\u2013specific enhancer\u2013promoter interactome maps and disease-risk association. Science 366, 1134\u20131139 (2019).","journal-title":"Science"},{"key":"1049_CR63","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/s41596-020-00472-3","volume":"16","author":"A Nott","year":"2021","unstructured":"Nott, A., Schlachetzki, J. C. M., Fixsen, B. R. & Glass, C. K. Nuclei isolation of multiple brain cell types for omics interrogation. Nat. Protoc. 16, 1629\u20131646 (2021).","journal-title":"Nat. Protoc."},{"key":"1049_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100358","volume":"2","author":"L Texari","year":"2021","unstructured":"Texari, L. et al. An optimized protocol for rapid, sensitive and robust on-bead ChIP-seq from primary cells. STAR Protoc. 2, 100358 (2021).","journal-title":"STAR Protoc."},{"key":"1049_CR65","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar, R., Domrachev, M. & Lash, A. E. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30, 207\u2013210 (2002).","journal-title":"Nucleic Acids Res."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01049-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01049-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01049-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T17:03:01Z","timestamp":1757264581000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-025-01049-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,24]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1049"],"URL":"https:\/\/doi.org\/10.1038\/s41531-025-01049-1","relation":{},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,24]]},"assertion":[{"value":"17 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Emily Rocha is an Associate Editor at npj Parkinson\u2019s disease","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"217"}}